0001562180-24-003439.txt : 20240417
0001562180-24-003439.hdr.sgml : 20240417
20240417160157
ACCESSION NUMBER: 0001562180-24-003439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240416
FILED AS OF DATE: 20240417
DATE AS OF CHANGE: 20240417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Humer Kristian
CENTRAL INDEX KEY: 0001872280
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 24850944
MAIL ADDRESS:
STREET 1: C/O VIRIDIAN THERAPEUTICS, INC.
STREET 2: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-04-16
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001872280
Humer Kristian
500 TECHNOLOGY SQUARE
SUITE 700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Financial Officer
false
Stock Option (Right to buy)
6.03
2024-04-16
4
A
false
275000.00
6.03
A
2034-04-15
Common Stock
275000.00
275000.00
D
The option vests as to 25% of the underlying shares of common stock on April 16, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.
/s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer
2024-04-17